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New methods employ RNA-seq to study single cells
within complex tissues by in situ sequencing or mRNA
capture from single photoactivated cells.promise for resolving the details of cell-type-specific ex-Introduction
An old adage relates how a drunk looks for his car keys
under a lamppost in the middle of the night - when
asked why he searches for the keys many meters away
from his car, where they presumably lie, the drunk an-
swers that it is ‘too dark over there’! The transcriptome -
defined as the set of all transcripts in a given sample - can
be cartooned as that lamppost. Unlike the proteome or
the metabolome, the transcriptome has the unique
property of being quantifiable thanks to the relative ease
of working with nucleic acids. Microarrays first took ad-
vantage of strand complementarity in the 1990s for glo-
bal gene-expression measurements, and, more recently,
with drops in the cost of sequencing, RNA sequencing
(RNA-seq) is now commonly used to profile the tran-
scriptome with unmatched resolution. Two new single-
cell transcriptomics methods further advance RNA-seq
by empowering the study of transcripts in their native
environments [1,2].The complexities of transcriptomics
As bright as the light cast by the transcriptome appears, it
must be acknowledged that it does not always translate to
biological function. Nonetheless, the transcriptome is at-
tractive because it is arguably the first phenotype of the
genome and it comprises the many recently recognized
groups of RNA, such as long non-coding RNAs and
microRNAs, in addition to protein-coding RNAs.
Examining transcriptomes in a complex, multicellular
sample often involves painful compromises. For example,* Correspondence: yanai@technion.ac.il
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bryonic time-course, not knowing which specific cell types
within the embryo are expressing the gene is a severe
handicap. Harnessing methods that can monitor gene ex-
pression at the level of individual cells thus holds great
pression. Moreover, even in a population of a given cell
type, variation in gene expression can illuminate import-
ant functional characteristics. For example, Shalek et al.
recently examined 18 cells and found extensive evidence
for bimodal gene expression within a population of im-
mune cells [3]. Characterizing such heterogeneity at a glo-
bal level could further expose unsuspected regulatory
mechanisms.
An amplification step exploiting the strand comple-
mentarity of nucleic acids is necessary in all single-cell
transcriptome methods (Figure 1a-c), including those
discussed below. In this context, James Eberwine first in-
troduced transcriptome amplification using T7 in vitro
transcription (IVT) [4]. For a single cell, three rounds of
IVT are required, yet the advantage of this approach re-
mains, in that amplification is linear, as opposed to the
exponential phase of PCR. IVT was used widely in most
gene-expression microarray platforms. With the intro-
duction of RNA-seq, samples can be molecularly bar-
coded, as in a recently introduced CEL-Seq method,
allowing for many single cells to be processed in parallel
and thereby requiring only a single round of IVT [5].
PCR-based single-cell transcriptome methods are also
available, each with distinct advantages [6-8]. More re-
cently, the notion of unique molecular identifiers
(known as UMIs) was introduced to tag transcripts be-
fore the reverse-transcription step, allowing for measure-
ment of individual transcripts with dramatically reduced
amplification bias [9].Single-cell transcriptomics in a complex tissue
In many projects, a particular cell type in a population
constitutes a rare subset. Examining these cells individu-
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Figure 1 New methods enable single-cell transcriptomics profiling of a complex tissue. (a) In single cell approaches, canonically, individual
cells are first dissociated and then isolated by micropipette, automated cell sorting, or microfluidics-enabled capturing. Cellular RNAs are then
amplified and sequenced. (b) The transcriptome of an individual cell can be determined by first photoactivating a TIVA-tag within that cell,
allowing it to hybridize to cellular mRNAs. These mRNAs can then be specifically purified and sequenced by any RNA-seq method. (c) FISSEQ
allows for RNA-Seq within the context of the cell by first fixing mRNA and then amplifying (by rolling circle amplification) and sequencing by the
SOLiD technology. FISSEQ: fluorescent in situ RNA sequencing; IVT: in vitro transcription; PCR, polymerase chain reaction; RNA-seq: RNA
sequencing; RT: reverse transcription; SOLiD; sequencing by oligonucleotide ligation and detection; TIVA: transcriptome in vivo analysis.
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transcriptomes. A recently published method from
Lovatt et al. now allows examination of the transcrip-
tome of an individual cell in a complex tissue by simply
shining a laser upon it [1]. This is made possible by
washing a live tissue with a transcriptome in vivo ana-
lysis (TIVA) tag, a cleverly designed molecule that, like a
Swiss Army knife, possesses many properties: a cell-
penetrating peptide, a photocleavable linker, the fluoro-
phores Cy3 and Cy5, a poly(U) oligonucleotide and
biotin (Figure 1b). Thanks to its cell-penetrating peptide,
the TIVA tag can permeate into the cells of a tissue;
however, by design, this entry causes the peptide to dis-
sociate from the TIVA tag, trapping it in the cell.Although all the cells in the tissue will contain TIVA
tags, these tags will not hybridize to cellular mRNAs as
their poly(U) oligonucleotides, which bind to mRNA
poly(A) tails, are normally hidden. Nevertheless, laser
photoactivation on a particular cell causes its TIVA tags
to come undone, as can be validated by fluorescence res-
onance energy transfer through exploiting the Cy3 and
Cy5 molecules on the tag. Once exposed, these tags can
then anneal to mRNAs in the light-selected cell and,
after harvesting RNA from the entire tissue, the desired
mRNA can be pulled out by using streptavidin beads
and then be sequenced (Figure 1b).
Lovatt et al. applied TIVA to study gene expression in
brain slices from mouse and human, where they detected
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interestingly, significantly more bimodal expression was
recorded in cells isolated from live tissues in comparison
with single neurons in culture, providing additional exam-
ples of the bimodality first characterized by Shalek et al.
[3]. An especially useful aspect of the TIVA method is that
it can be used to connect the particular morphology of a
cell to its transcriptome. The TIVA method is thus the
first approach to allow for the study of the transcriptome
in cells within intact tissues. This provides a significant ad-
vance over methods such as laser capture or isolation by
pipette (Figure 1a), which can either injure the cell in the
collection process or only partially collect the cell - relevant
especially for cells, such as neurons, that possess complex
morphologies.
In situ sequencing for all transcripts in individual
cells
As mentioned above, single-cell transcriptomics requires
amplification, a step that, until now, has involved RNA
collection and thus loss of the cellular context of each
RNA. In cases where cellular localization information is
desired (of mRNA or protein), in situ hybridization is an
option, but the capacity of this approach is limited to
only a handful of genes at a time. Recently, Ke et al. in-
troduced a method for sequencing RNA in situ and
showed that short 4-bp reads can detect point mutations
in selected genes [10]. Meanwhile, Lee et al. have now
demonstrated a novel approach that takes this a dra-
matic step forward by profiling the transcriptome in situ
in fixed cells, in a method termed fluorescent in situ
RNA sequencing (FISSEQ) [2]. This science-fiction-like
method relies on performing RNA-seq directly in the
cells of interest, through a combination of in situ RNA
amplification in a fixed sample and sequencing by oligo-
nucleotide ligation and detection (SOLiD).
FISSEQ involves the reverse transcription of RNAs in
fixed cells with dNTPs enriched with aminoallyl-modified
dUTPs (aaUTPs; see Figure 1c). These cDNAs are then
fixed to the cell protein matrix using a crosslinker that ex-
ploits the NH group of the aaUTPs. Rolling circle amplifi-
cation on the fixed cDNA produces a long single-stranded
cDNA for each transcript that can then be sequenced in
situ using the SOLiD sequencing platform.
Lee et al. show that the amplification step is able to
work in mouse embryos, mouse brain, Drosophila em-
bryos, HeLa cells, human primary fibroblasts and human
induced pluripotent stem cells. For fibroblast cells, the
authors also sequence amplicons and report a transcrip-
tome visualized within the confines of cellular mem-
branes. The SOLiD sequencing of these cells yields 27-bp
reads for 15,000 amplicons covering 4,000 genes. As
the reverse-transcription step begins with random hex-
amers (as opposed to the poly(U) oligonucleotidesoften used in other protocols, including TIVA), the
transcriptome is expected to include a sizeable fraction
of non-mRNA transcripts. Yet, for fibroblasts, Lee
et al. reported that 44% of transcripts were mRNAs,
which could be attributed to the enrichment of dis-
tinctly localized mRNAs that are more resolvable by
FISSEQ. When the transcriptome was again probed
during simulated wound healing, the mRNA fraction
dropped to 7%. Comparing these transcriptomes, the
authors found that the differentially expressed genes
matched those previously implicated in wound healing.
A comparison of FISSEQ with traditional RNA-seq
showed that the two methods were generally well corre-
lated. However, the correlation was notably poor for
RNAs involved in RNA and protein processing, leading
the authors to make the interesting suggestion that these
RNAs localize to cellular structures that are effectively
inaccessible to FISSEQ. The ability to establish the
localization of gene expression in many cells in parallel
will likely make FISSEQ the method of choice for many
single-cell transcriptomics applications.
Discussion
The holy grail of single-cell transcriptomics is to identify
the transcript abundance of all genes in a cell positioned
in its native environment across both space and time,
and to do so without compromising the viability of the
cell. Along these lines, TIVA constitutes a major step
forward and should prove invaluable in identifying inter-
cellular relationships by enabling analyses of the tran-
scriptomes of neighboring cells at a high level of
resolution. Also among the strengths of TIVA as a tech-
nology is its accessibility as it appears reasonably friendly
to the uninitiated, relying upon commonly available
tools.
A noteworthy strength of the FISSEQ method, mean-
while, is that it promises to reveal the spatial substructure
of the transcriptome. Knowledge of where particular
transcripts reside in cells could also enable a guilt-by-
association approach to identifying functional relation-
ships between genes. With FISSEQ, one exciting prospect
is the high-resolution determination of the characteristic
path of a transcript-type in the cell throughout its pro-
gram. Imagining FISSEQ analysis on thousands of cells,
the portfolio of locations of a particular transcript type
may be interpreted to reveal its cellular program. Such a
brightly lit transcriptome could perhaps unlock some of
the remaining mysteries of the cell.
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